Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
04/2006
04/11/2006US7025814 Ink-jet ink, an ink-jet recording material or an ink-jet system containing at least one water-soluble hindered amine compounds of the general formula (I) or (II): wherein G1 and G2 are independently alkyl of (1) to (4) carbon atoms or
04/11/2006CA2282840C S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist
04/06/2006WO2006037047A2 The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
04/06/2006WO2006037043A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
04/06/2006WO2006037042A1 Fexofenadine crystal form and processes for its preparation thereof
04/06/2006WO2006036936A2 The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
04/06/2006WO2006036874A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation
04/06/2006WO2006036664A1 Substituted sulfonamidopropionamides and methods of use
04/06/2006WO2006035433A2 Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
04/06/2006WO2006004793A3 Hetero isonipecotic modulators of vanilloid vr1 receptor
04/06/2006WO2005102335A3 Methods of treating sleep disorders
04/06/2006US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors
04/06/2006US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors
04/06/2006US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/06/2006US20060074107 Pharmaceutically active piperidine derivatives
04/06/2006US20060074098 Methods of treatment of amyloidosis using ethanolcyclicamine aspartyl protease inhibitors
04/06/2006US20060074085 Bcl-XL inhibitors; N-{[4-({(1R)-5-(dimethylamino)-1-[(phenylthio)methyl]pentyl}amino)-3-nitrophenyl]sulfonyl}-4-(4-fluorophenyl)piperidine-1-carboxamide; useful for promoting apoptosis; Anticancer agents; autoimmune diseases; antiinflammatory agents
04/06/2006DE102004046497A1 Donepezil-Salze Donepezil salts
04/06/2006CA2581926A1 Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
04/06/2006CA2580461A1 Substituted sulfonamidopropionamides and methods of use
04/06/2006CA2580136A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
04/06/2006CA2580129A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation
04/05/2006EP1642892A1 Lactone-added hindered amine compound
04/05/2006EP1642880A1 Hsp90 family protein inhibitors
04/05/2006EP1642578A2 Fentanyl composition for nasal administration
04/05/2006EP1641771A1 Hydroxamate sulfonamides as cd23 shedding inhibitors
04/05/2006EP1641757A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
04/05/2006EP1641756A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
04/05/2006EP1641755A1 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (gcs) inhibitor
04/05/2006EP1641748A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease
04/05/2006EP1641729A2 Use of functionalized onium salts as a soluble support for organic synthesis
04/05/2006EP1641493A1 Radiolabeled cannabinoid-1 receptor modulators
04/05/2006EP1245564B1 Benzamidine derivatives
04/05/2006EP1140846B1 Aspartic protease inhibitors
04/05/2006EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia
04/05/2006EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
04/05/2006CN1756743A Process for the preparation of fexofenadine
04/05/2006CN1756740A Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
04/05/2006CN1249064C Tosylate and benzene sulfonate of pyrazolopy ridone compound
04/05/2006CN1249035C 4-imino-N-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators
04/04/2006US7022880 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid compounds prepared by acylation of a substituted piperidine derivative; intermediates to terfenadine carboxylic acid metabolite and related compounds
04/04/2006US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy
04/04/2006US7022736 Enzyme inhibitors
04/04/2006US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/04/2006US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
04/04/2006US7022703 Acetylenic compound useful in treating inflammatory disorders
04/04/2006US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
04/04/2006CA2235133C Esters of 3-hydroxy-piperidinemethanol derivatives
04/04/2006CA2188507C Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same
04/04/2006CA2166315C Process for the preparation of thalidomide
03/2006
03/30/2006WO2006032994A2 Muscarinic receptor antagonists
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006WO2004053071A3 Method for discovering neurogenic agents
03/30/2006US20060069255 Novel aryl ureido benzoic acid derivatives and their use
03/30/2006US20060069125 Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
03/30/2006US20060069120 Novel piperidine derivaties as modulators of chemokine receptor ccr5
03/30/2006US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/30/2006US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
03/30/2006CA2580725A1 Novel heterocyclic nf-kb inhibitors
03/29/2006EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
03/29/2006EP1639029A2 Biodegradable poly(beta-amino esters) and uses thereof
03/29/2006EP1638940A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
03/29/2006EP1638939A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/29/2006EP1638935A1 Nk1 antagonist
03/29/2006EP1638932A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
03/29/2006EP1638565A2 Substituted piperidine compounds and methods of their use
03/29/2006EP1638564A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opioid receptors ligands
03/29/2006EP1638560A1 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
03/29/2006EP1638551A2 Immunosuppressant compounds and compositions
03/29/2006EP1379234B1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf
03/29/2006CN1753871A Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
03/29/2006CN1753870A Novel benzamide derivatives and process for production thereof
03/29/2006CN1753866A Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals
03/29/2006CN1752086A Improved method of preparing azhediping
03/29/2006CN1247587C Tert. alkylphenoxy substituted polycyclic compounds
03/29/2006CN1247543C Method for the production of biperiden II
03/29/2006CN1247541C Cyclic imines as pesticides
03/28/2006US7019161 Processes for the preparation of 3-aminocarboxylic acids and their esters
03/28/2006US7019053 Stabilizer mixtures
03/28/2006US7019030 Immunotherapeutic agents
03/28/2006US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
03/28/2006US7019019 Matriptase inhibitors and methods of use
03/28/2006US7019017 Small molecule inhibitors of HER2 expression
03/28/2006US7019007 CCR-3 receptor antagonists (I)
03/28/2006US7019003 Bactericides
03/28/2006US7018642 Compounds, compositions, and methods for controlling biofilms
03/28/2006CA2164677C Stabilized polyvinyl chloride
03/28/2006CA2147451C 3-indolylpiperidines
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006031674A1 Process for preparing n-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates
03/23/2006WO2006030984A1 Piperidine compound and process for preparing the same
03/23/2006WO2006030975A1 Piperidine derivatives and use thereof
03/23/2006WO2006030931A1 N-substituted n-(4-piperidinyl)amide derivative
03/23/2006WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
03/23/2006WO2006030249A1 Donepezil salts suitable for the preparation of pharmaceutical compositions
03/23/2006WO2006029906A1 Methylene dipiperidine derivatives
03/23/2006WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
03/23/2006WO2004101507A3 N-sulphonylated amino acid derivatives and use thereof as matriptase inhibitors
03/23/2006US20060063933 Process for production of carebastine
03/23/2006US20060063808 using isobutyrate or an isobutyrate equivalent